Halozyme Therapeutics, Inc.HALONASDAQ
LOADING
|||
Switch Symbol:
Analysts lean bullish — 62% recommend buying.
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Current price is 4% above analyst consensus — near fair value expected.
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.